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ABSTRAK 
 
Pengenalan: Hemodialisis merupakan rawatan penggantian ginjal terhadap kegagalan 
ginjal peringkat terakhir. Perubahan tekanan mata berlaku semasa hemodialisis. 
Seseorang yang ada masalah pengaliran akueous lebih berisiko mendapat gejala kenaikan 
tekanan mata. Perubahan ketebalan kanta boleh mengakibatkan perubahan kedalaman 
ruang depan mata yang boleh memudaratkan lagi masalah pengaliran akueous. 
Pengesanan awal perubahan kanta semasa hemodialisis dapat mencegah kenaikan 
tekanan mata dan kebutaan. Oleh demikian, penilaian perubahan ketebalan kanta dan 
kedalaman ruang depan mata dengan tekanan mata semasa hemodialisis adalah penting.   
 
Objektif:  Untuk menentukan min ketebalan kanta dan hubungan di antara ketebalan 
kanta dan kedalaman ruang depan mata,  antara kedalaman ruang depan mata dan tekanan 
mata  serta  antara ketebalan kanta dan tekanan mata semasa hemodialisis. 
  
Tatacara:  70 mata dari 70 peserta kajian yang dipilih dari Unit Hemodialisis, Hospital 
Queen Elizabeth. Ketebalan kanta, kedalaman ruang depan mata dan tekanan mata diukur 
pada 0 jam, 2 jam dan 4 jam hemodialisis. Perubahan ketebalan kanta, kedalaman ruang 
depan mata dan tekanan mata berdasarkan masa hemodialisis dikaji dengan ujian statistik 
‘repeated measures ANCOVA’ dan ‘multiple paired samples T-test’ dengan ‘bonferonni 
correction’(p=0.017). Hubungan di antara parameter kajian ditentukan dengan 
‘correlation analysis’. 
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Keputusan: Kajian menunjukan peningkatan ketebalan kanta dan tekanan mata yang 
signifikan untuk keseluruhan peserta kajian sebanyak 0.21 ± 0.69 mm (p=0.015) dan 1.26 
± 3.02mmHg (p=0.001) dalam masa 2 jam yang pertama hemodialisis. Perubahan 
kedalaman ruang depan mata adalah tidak signifikan. Peningkatan min ketebalan kanta 
dan tekanan mata adalah lebih ketara dalam kumpulan diabetik dan umur tua dalam masa 
2 jam yang pertama hemodialisis tetapi hanya perubahan tekanan mata  adalah signifikan. 
Pada jam ke-2 hemodialisis, ia menunjukan hubungan songsang di antara ketebalan kanta 
dan kedalaman ruang depan mata, hubungan songsang di antara kedalaman ruang depan 
mata dan tekanan mata serta hubungan linear di antara ketebalan kanta dan tekanan mata 
tetapi tidak signifikan. Pada jam ke-4 hemodialisis, ia menunjukan hubungan songsang 
yang memuaskan dan signifikan di antara ketebalan kanta dan kedalaman ruang depan 
mata (r = -0.286, p=0.016) tetapi hubungan parameter yang lain adalah tidak signifikan.  
 
Kesimpulan:  Dalam masa 2 jam pertama hemodialisis,  peningkatan ketebalan kanta 
dan tekanan mata adalah signifikan tetapi  hubungan di antara parameter kajian adalah 
tidak signifikan mencadangkan mekanisma kenaikan tekanan mata adalah bukan 
disebabkan oleh ketebalan kanta sahaja. Hubungan songsang yang signifikan di antara 
ketebalan kanta dan kedalaman ruang depan mata terjadi pada jam ke-4 hemodialisis 
tetapi ia tidak menyebabkan kenaikan tekanan yang signifikan di dalam mata yang 
normal.  Kenaikan tekanan mata boleh menjadi signifikan sekiranya seseorang 
mempunyai mata yang bermasalah pengaliran akueous. Diabetes mellitus dan umur 
mempunyai kesan yang signifikan pada tekanan mata tetapi tiada kesan signifikan pada 
ketebalan kanta dan kedalaman ruang depan mata semasa hemodialisis. 
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ABSTRACT 
 
Introduction: Hemodialysis is a common renal replacement therapy in the end stage 
renal failure. Fluctuation of intraocular pressure occurred during hemodialysis. 
Individuals with compromised aqueous outflow facility have increased risk of 
symptomatic elevation of intraocular pressure. Lens thickness changes may result in 
alteration of anterior chamber depth that can further compromise aqueous drainage. Early 
detection of the lens thickness changes during hemodialysis can prevent elevation of 
intraocular pressure and visual loss. Thus, evaluation of the lens thickness and anterior 
chamber depth with intraocular pressure changes during hemodialysis are essential.   
 
Objectives: To determine the mean lens thickness and  the relationship between lens 
thickness and anterior chamber depth, between anterior chamber depth and intraocular 
pressure as well as between lens thickness and intraocular pressure during hemodialysis. 
  
Methodology: 70 eyes from 70 study subjects were recruited from Hemodialysis Unit, 
Queen Elizabeth Hospital. Lens thickness, anterior chamber depth and intraocular 
pressure were measured at 0hour, 2hour and 4hour of hemodialysis. The mean lens 
thickness, anterior chamber depth and intraocular pressure changes based on time effect 
of hemodialysis were analyzed with repeated measures ANCOVA and multiple paired 
samples T-test with bonferonni correction (p=0.017). The relationship between study 
variables were evaluated with  correlation analysis. 
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Results: There were significant increased mean lens thickness and intraocular pressure 
among all study subjects by 0.21 ± 0.69 mm (p=0.015) and 1.26 ± 3.02mmHg (p=0.001) 
in the first 2hours of hemodialysis. The anterior chamber depth changes was insignificant. 
The mean lens thickness and intraocular pressure were increased more in diabetic and 
older age group in the first 2hours of hemodialysis but significant for intraocular pressure 
changes only. At 2hours of hemodialysis, there were inverse correlation between lens 
thickness and anterior chamber depth, inverse correlation between anterior chamber and 
intraocular pressure, and linear correlation between lens thickness and intraocular 
pressure but not significant. At 4hour of hemodialysis, there was a significant fair inverse 
correlation between lens thickness and anterior chamber depth (r = -0.286, p=0.016) but 
the correlation between other variables were not significant. 
 
Conclusions:  In the first 2hours of hemodialysis, there were significant increased mean 
lens thickness and intraocular pressure but no significant  correlation between study 
variables suggested  other mechanisms of raised intraocular pressure were involved rather 
than due to lens thickness changes only. A significant inverse relationship between lens 
thickness and anterior chamber depth was established at 4hours of hemodialysis but it 
didn’t lead to significant raised intraocular pressure in normal eyes. Intraocular pressure 
rise may become significant if  individuals have compromised aqueous drainage. 
Diabetes mellitus and age had significant influence on intraocular pressure but not on 
lens thickness and anterior chamber depth during hemodialysis. 
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1.1 BACKGROUND OF THE STUDY 
 
 
Chronic kidney disease is a disease that occurs gradually, over months to years, with loss 
of the renal function over time.  Chronic kidney disease is divided into 5 stages of 
increasing severity based on the glomerular filtration rate (GFR). GFR is the standard 
means of expressing overall renal function. Normal GFR is 100-140ml/min in men and 
85-115ml/min in women. GFR decreases  with age and it falls with the progress of 
kidney diseases.  Stage 5 chronic kidney is referred as end stage renal failure. The GFR 
of this stage 5 CKD is less than 15ml/min/1.73m2. At this stage , there is total or near 
total loss of the kidney function. Complication of end stage renal failure such as  
accumulation of water, waste products and toxic substances in the body,  anemia, high 
blood pressure, metabolic acidosis,  and bone disease. At this stage, most individuals 
need renal replacement therapy. (Eknoyan G, 2002). 
 
 Center of disease control of United States reported that the prevalence of chronic kidney 
disease was increased. There were 16.8% of the United States , population aged more 
than 20 years old had chronic kidney disease in 1999 to 2004 data compared to 14.5% in 
1988 to 1994 data. Individuals with cardiovascular disease and diabetes mellitus had 
greatest risk of chronic kidney disease. Age group more than 60 years old (39.4%) was 
more prevalent than  others. They also reported that the non-Hispanic blacks (19.9%) and 
Mexican America (18.7%) were more prevalent than non-Hispanic whites (16.1%) 
( Saydah et al., 2007). 
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The major causes of chronic kidney disease are diabetes mellitus and hypertension.    
Other causes of chronic kidney disease are glomerulonephritis (post infection and 
systemic lupus erythematosus), polycystic kidney disease, analgesic (acetaminophen and 
ibuprofen), and obstructive nephropathy ( stones, benign prostatic hyperplasia, stictures, 
tumours). 
  
 The prevalence of chronic renal failure cases is increasing in Malaysia.  According to the 
Malaysian Dialysis and Transplant Registry 2010, there were 4521 new dialysis patients 
in 2010 compared to 2112 new dialysis patients in 2001. The commonest primary renal 
disease of new dialysis patients was diabetic nephropathy (56%), followed by unknown 
cause (30%), hypertension (8%), glomerulonephritis (3%), systemic lupus erythematosus 
(1%), polycystic kidney (1%), and obstructive nephropathy (1%) (Lim et al., 2011). 
 
Hemodialysis is a kind of renal replacement therapy for end stage renal disease. The early 
concept was first presented in 1854 by Thomas Graham of Glasgow about the principles 
of solute transport across a semipermeable membrane (Graham, 1854).  Later, the 
artificial kidney was first developed by Abel, Rountree and Turner in 1913. They 
performed dialysis on animals (Abel et al., 1913). Georg Hass was  the inventor of 
dialysis in humans. He performed the first time an extracorporeal dialysis successfully in 
humans in 1924. Kolff developed the clinically useful artificial kidney apparatus in 1943 
(Kolff & Berk, 1944, Gordon et al., 2000). 
 
 3 
The mechanism of hemodialysis applied the principle of diffusion across semi permeable 
membrane.  The solutes will diffuse across the semipermeable membranes,  followed the 
concentration gradient from high concentration to the low concentration.. Therefore, 
solutes like urea with higher concentration in the blood will diffuse across the membrane 
in the dialyzer to the dialysate fluid and bicarbonate with higher concentration in 
dialysate will diffuse to the blood. This principle allows removal of uraemic toxins and 
provides adequate balance of fluids, electrolytes and acid-base in hemodialysis (Figure 
1.1). 
 
 
 Figure 1.1: Schematic diagram of mechanism of diffusion in hemodialysis 
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There are systemic and ocular complication of hemodialysis either in immediate or long 
term effects of hemodialysis. The common systemic effects are low blood pressure, 
fatique, nausea and headaches because of  removal of too much fluids or too rapidly. 
Serious systemic complications were reported such as thromboembolism, anaphylactic 
reaction, first use syndrome, bacteraemia, endocarditis, and stroke ( LeSar et al., 1999, 
Liangos, 2005, Willicombe, 2010, Fitzgibbons, 2011, Wells & Foroozan, 2004).  
 
Ocular abnormalities occur frequently in chronic renal failure patients on hemodialysis. 
These ocular manifestations are a result of uremia and abnormal electrolyte and fluid 
homeostasis that occurs with hemodialysis.  Ocular abnormalities such as low or raised 
intraocular pressure during hemodialysis, cataract , band keratopathy, calcification of 
cornea and conjunctiva, retinal detachment, macular leakage,retinal hemorrhage, anterior 
ischemic optic neuropathy and uremic optic neuropathy (Eastherbrook & Mortimer, 1970, 
Popa & Nicoara, 2000, Evans & Rosner, 2005).  
 
Cataract is the long term effect of end stage renal failure  and chronic hemodialysis 
(Berlyne et al., 1972,  Koch et al., 1976, Stein & Godel, 1980, Kazi et al., 1984, Haviv et 
al., 1999, Evans & Rosner, 2005).  High blood urea and hypocalcemia  in end stage renal 
failure(ESRF) contribute to cataract formation. One theory was that urea trapping in the 
lens causes chronic water accumulation within the lens lead to an osmotic cataract 
(Berlyne et al., 1972). Bilateral cataract due to hypocalcemia secondary to renal failure 
were found in young patients (Berlyne et al., 1972, Koch et al.,1976, Stein & Godel, 
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1980, Kazi et al., 1984).   In hemodialysis, there is intermittent fluxes of fluid into and 
out of lens which lead to cataract formation (Evans & Rosner, 2005). Chronic 
hemodialysis has been shown to contribute to the development of rapid progress of 
cataracts in patients with chronic renal failure (Haviv et al., 1999). 
 
So far, there were studies on intraocular pressure changes during hemodialysis. Some 
reported raised intraocular pressure during hemodialysis (Sitprija et al., 1964,  Gafter et 
al., 1985, Cecchin et al., 1986, Tawara et al., 1998, Tovbin et al.,  2002 ) and some 
reported differently (Ramsell et al.,  1971 , Gutmann and Vaziri, 1984, Rever et al., 1981, 
De marchi et al., 1989).  In low intraocular pressure, it is due to ultrafiltration process. 
Ultrafiltration during hemodialysis lead to gradual reduction of extracellular fluid 
compartment. This increase the oncotic pressure of extracellular  space. Subsequently,  
draw fluids out from the surrounding tissues and decrease aqueous humour production 
lead to low intraocular pressure (Tokuyama et al., 1998).  In raised intraocular pressure, it 
is due to rapid removal of uremic toxins. Rapid removal of uremic toxins and other 
solutes from the vascular compartment during hemodialysis lead to decrease serum 
osmolality. These serum osmolality is lower more rapidly than ocular osmolality lead to 
water movement into the aqueous humor. Subsequently, increased aqueous humor 
production and  raised intraocular pressure (Watson & Greenwood, 1966, Tawara et al., 
1998).  Significant raised intraocular pressure occurs especially  in patients with existing 
impaired aqueous outflow  such as  narrow or closed angle (Tawara et al., 1998, Yoon et 
al., 2000, De Marchi et al., 1989).   
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Significant elevation of IOP is an important risk of glaucoma that causes irreversible 
ganglion cell damage. Excessive elevation of intraocular pressure leading symptomatic 
eye pain, headache and blurring of vision during hemodialysis (Cechhin et al., 1986,  
Tawara et al., 1998,  Minguela et al., 2000, Yoon  et al., 2000 ). Miguela et al. (2000) 
reported that there were symptomatic ocular pain in diabetic patient during hemodialysis. 
By alteration the dialysis parameter and added a colloid solution at the beginning of  
hemodialysis, the elevation of intraocular pressure was prevented and the patient became 
asymptomatic.  However, other studies showed that changes of IOP was not statistically 
significant (Broekema et al., 1988,  Hojs & Pahor, 1997). Broekema et al. (1998) 
conducted a study of intraocular pressure changes during hemodialysis,  they found that 
there were no significant intraocular pressure changes at hourly interval for 4hours of 
hemodialysis in 14patients.  Hojs & Pahor (1997) found that there were no statistically 
significant differences of intraocular pressure before and after hemodialysis and also no 
correlation between intraocular pressure, blood pressure and body weight changes.  
 
 Changes of intraocular pressure during hemodialysis are influenced by the serum 
osmolality and the aqueous outflow facility based on previous studies. Thereotically, The 
aqueous outflow facility is affected by the angle and depth of the anterior chamber. 
Changes in lens thickness are important and play role in alteration of anterior chamber 
depth  and monitoring the cataract progression ( Jivrajka et al, 2008).   
 
Lens thickness is the anteroposterior diameter of lens.  In normal person,  lens thickness 
is 3.5mm at birth and 5mm in adult ( Khurana, 2002).  The normal central anterior 
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chamber depth is 3mm ( Snell & Lemp, 1998).  The lens thickness changes with age 
( Zadnik et al., 1995, Richdale et al., 2008 ).  Zadnik et al. (1995) reported the 
crystallines lens has been shown to thin nearly 0.20mm over 4 years from ages 6 to 10 
years  to compensate for an average increase in axial length of 1mm where as Richdale et 
al. (2008) found that the overall lens thickness increases linearly by 0.013 to 
0.029mm/year because the crystalline lens continues to mature and more lens fibers are 
added within the capsular bag.  The increased of lens thickness due to increased of the 
lens cell number and mass may account for the risk of  development of cataracts (Shui & 
Beebe, 2008). 
              
Praveen et al. (2008) found that lens thickness varied with axial length and  age. 
Advancement in axial length associated with lens thickness decreased by 0.004mm. 
where as advancement with each decade of  age, showed lens thickness increased by 
0.155mm. Besides, there was significant decreased in anterior chamber depth by  mean 
difference  0.44mm  with advancement in lens thickness (p<0.001).  In addition, Lim et 
al. (2006) revealed acute primary angle closure eyes had significant shallower anterior 
chamber depth and more anterior position of lens.  
 
According to Schafer et al. (2006), they found recurrent elevation of intraocular pressure 
during hemodialysis. They reported raised intraocular pressure of 10-12mmHg and   
intumescence lens with ciliary block.  Rapid decrease of serum osmolarity during 
hemodialysis lead to fluids flux in and out of lens and subsequently, lens swelling with 
ciliary block. 
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Dynamic equilibrium between the aqueous humour formation, outflow facility and 
episcleral venous pressure are essential to maintain the normal intraocular pressure. 
Alteration of lens thickness leading to lens position and anterior chamber depth changes. 
The aqueous outflow facility is affected by the changes of the lens position and anterior 
chamber depth.  The raised intraocular pressure becomes more significant during 
hemodialysis if the individuals have compromised outflow facility.  
 
The outflow facility plays role in IOP changes during hemodialysis was reported by 
Tawara et al. (1998)  and Yoon et al. (2000). Tawara et al. (1998) found that patients 
with  impaired aqueous outflow had significant rise in intraocular pressure during 
hemodialysis. Yoon et al. (2000) reported that the intraocular pressure was elevated more 
than 4mmHg during hemodialysis in 20 of 36  post vitrectomy eyes (55.6%) compared to 
18 of 138 non operated eyes (13%). Symptomatic high intraocular pressure was 5 of 36 
post vitrectomy eyes (14%).The early post vitrectomy eyes have acute post operative  
compromised aqueous outflow. Therefore, increased the risk of elevation of intraocular 
pressure. IOP elevation was well compensated in the patients with normal aqueous 
outflow system ( Tawara et al., 1998,  Yoon  et al., 2000). Therefore, individuals who 
have compromised aqueous outflow facility such as peripheral anterior synechiae,   
narrow or closed angle, tendency to have significant raised intraocular pressure and 
glaucoma attack during hemodialysis. 
  
Aqueous drainage is influenced by age and disease. There are two normal anatomical 
areas of resistance to the circulation of aqueous humor in the eyes such as the area that 
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the anterior surface of the lens is in contact with the iris (iris lens resistance area) and the 
angle of anterior chamber  where the aqueous leaves the anterior chamber to enter the 
veins. Diabetes mellitus and age are factors may increase the iris lens resistance . With 
increased with age, there are changes with trabecular meshwork such as thickening of the 
columns and deposition of melanin debris blocking the passages leading to decreased of 
aqueous outflow. Therefore, diabetic and old age individuals are tendency to have high 
intraocular pressure than others ( Snell & Lemp, 1998).  
  
 
1.2 A-SCAN AND PERKINS TONOMETER 
 
 
A-Scan and Perkins tonometer are handheld instruments that suitable and convenient  to 
measure lens thickness, anterior chamber depth and intraocular pressure of  the eyes 
during hemodialysis.  However, these instruments are operator dependent. Therefore, 
error of measurement is minimized by taking the average reading of multiple 
measurements by the same operator.  
 
A-scan  is the gold standard for both clinical and research to measure the thickness of 
crystalline lens and the depth of the central anterior chamber.  A-scan works on the 
principle of ultrasound that the velocity of sound waves vary as they travel through 
different medium. Ultrasound is the sound waves that the sound frequency of greater than 
20,000 Hz (20 KHz ). In ophthalmology, A-scan ultrasound probes use a frequency of 
approximately 10 million Hz (10 MHz).  This extremely high frequency allows excellent 
resolution of small structures. The velocity of sound is determined by the density of the 
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medium.  Sound waves travel faster through solids than through liquids medium. The 
ultrasound passes through the eye and is reflected from the posterior corneal surface, the 
anterior and posterior surface of the lens, the retina and the sclera. The pulse-echo times 
are recorded. By determining the time for sound waves to travel through the crystalline 
lens and anterior chamber depth,  the lens thickness and anterior chamber depth can be 
calculated. The faster the sound wave travels, the thinner the lens thickness and the 
shorter the anterior chamber depth.   
 
There are other modalities of instruments that measure anterior chamber depth and lens 
thickness. Although the measurements and principles of the instruments are different. A-
scan is still the gold standard measurements and the measurements are acceptable 
clinically. Hashemi et al. (2005) conducted a study for comparison of  measurement of  
anterior chamber depth using A-scan ultrasonography (Echoscan), Orbscan II, and 
IOLMaster. They found that A-scan has the mean differences of anterior chamber depth 
compared to other instruments were very small and clinically negligible. The mean 
difference of  anterior chamber depth between Orbscan II and Echoscan was -0.03 ± 0.12 
mm and between IOLMaster and A-scan measurements  was +0.09 ± 0.14 mm. Orbscan 
II  measurements were lower than Echoscan measurements of anterior chamber depth 
where as IOLMaster showed higher than Echoscan measurements.  
 
Zeng et al.( 2008) found that  the lens thickness measurements by anterior segment 
optical coherence tomography and A-scan ultrasonography were slightly different. 
Anterior segment optical coherence tomography measurements were significantly greater 
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than A-scan measurements by  0.135 mm in elderly and 0.101 mm in younger subjects. 
Among all of these instruments,  A-scan is still the most convenient handheld instruments 
for lens thickness and anterior chamber depth measurements of the end stage renal failure 
patients during hemodialysis at hemodialysis unit. 
 
The gold standard instrument to measure intraocular pressure is goldmann applanation 
tonometer. However, it is not a convenient instrument to measure intraocular pressure 
during hemodialysis because it needs to work together with a slit lamp. Perkins tonometer 
is a handheld tonometer that works with the same principle of goldmann applanation 
tonometer that based on Imbert-Fick principle.  This principle states that the pressure 
inside the sphere (P) equals the force necessary to flatten its surface (F) divided by the 
area of flattening (A) ,  P =F/A. (Figure 1.2) (Kanski, 2003). 
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Figure 1.2: Imbert-Fick principle of applanation tonometry 
 
The mean intraocular pressure measurements by perkins tonometer is slightly different 
than the goldmann applanation tonometer. Dos Santos et al. (1998) reported the mean 
difference between the goldmann applanation tonometer and perkins tonometer were 0.34 
± 0.69mmHg in the right eye and 0.33 ± 0.82mmHg in the left eye of the control group. 
In this study, they found goldmann applanation tonometry showed false elevated 
intraocular pressure readings in obese individuals due to transitory elevation of 
intraocular pressure. This elevated intraocular pressure was believed due to simultaneous 
breath-holding and thorax compression leading to increased venous pressure in obese 
individuals. The mean intraocular pressure was 20.9 ± 2.28mmHg in the right eye and 
21.4 ± 3.16mmHg in the left eye of obese individuals by using goldmann applanation 
tonometer where as  perkins tonometery showed  16.3 ± 2.39mmHg for the right eye and 
F 
P 
A 
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16.3 ± 2.42mmHg for the left eye. Therefore, false diagnosis of glaucoma in obese 
individuals can be avoided by perkins tonometry.  
 
The perkins tonometer was the most reliable in measuring intraocular pressure with 
significant less variability ( Lim et al., 2005). Lim et al. (2005) also found that tonopen 
XL, perkins tonometer and pneumatonometer underestimated the actual intraocular 
pressure. Perkins tonometer was more accurate than pneumatonometer where as tonopen 
has less inaccuracy than perkins tonometer.  
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1.3 RATIONALE OF THE STUDY 
 
 
Elevation of intraocular pressure is a complication of hemodialysis.  Lens thickness 
changes may result in alteration of anterior chamber depth that can compromise aqueous 
drainage. Individuals with compromised aqueous outflow facility have increased risk of 
symptomatic elevation of intraocular pressure during hemodialysis. 
 
There were many studies on intraocular pressure changes during hemodialysis.  
but not on lens thickness and anterior chamber depth changes during hemodialysis. So far,  
no major or serial studies on the lens thickness changes during hemodialysis. Therefore, 
the significant of lens thickness changes during hemodialysis is still debatable. To the 
best of my knowledge, there is no data of lens thickness changes during hemodialysis in 
local study. 
 
Evaluation of the lens thickness and anterior chamber depth with intraocular pressure 
changes during hemodialysis are essential.  This will help us to determine whether the 
changes of lens thickness and anterior chamber depth with intraocular pressure are 
significant or not  and to determine the important to have the baseline measurement of 
lens thickness prior to hemodialysis to anticipate acute intraocular pressure rise during 
hemodialysis in future. Based on these data of lens thickness changes during 
hemodialysis, it  can help us to consider early removal of cataract and to prevent 
symptomatic elevation of intraocular pressure or  acute angle closure glaucoma.  
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 2.1 GENERAL OBJECTIVE 
 
      To determine the relationship of lens thickness and anterior chamber depth with  
      intraocular pressure during hemodialysis.  
 
 
 2.2 SPECIFIC OBJECTIVES 
 
(i) To determine the changes of mean of lens thickness during hemodialysis.   
 
(ii)  To determine the relationship of lens thickness(LT) and anterior chamber 
depth(ACD) during hemodialysis. 
 
(iii) To determine the relationship of anterior chamber depth(ACD) and intraocular 
pressure (IOP) during hemodialysis. 
 
(iv) To determine the relationship of lens thickness(LT) and intraocular 
pressure(IOP) during hemodialysis. 
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3.1 STUDY DESIGN 
 
A cross sectional study was carried out to determine the relationship of lens thickness and 
anterior chamber depth with intraocular pressure during hemodialysis.  
 
3.2 POPULATION, PLACE AND TIME 
 
3.2.1 Study population 
Subjects were recruited based on the selection criteria among the patients from 
Hemodialysis Unit, Queen Elizabeth Hospital. 
 
3.2.2 Place of study 
Hemodialysis Unit, Queen Elizabeth Hospital. 
 
3.2.3 Period of study 
November 2009 to December 2010 
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3.3 ETHICAL DISCLOSURE 
 
The study was approved by Research and Ethical committee, Universiti Sains Malaysia 
and Health Ministry Malaysia. The study was conducted in accordance with the ethical 
standards stated in the Declaration of Helsinki of human research. Written and informed 
consent was obtained from all the subjects.   
 
3.4 SAMPLING METHOD AND SAMPLE SIZE 
 
3.4.1 Sampling Method 
Simple random sampling 
 
3.4.2 Selection of the Eyes   
Each individual will be numbered and only one eye will be selected in the study. Right 
eye will be selected for those with odd number and left eye for even number. However, if 
the selected eye does not meet the criteria, the fellow eye will be selected in the study. 
Purpose of this randomization of  eyes  was to prevent selection bias.  
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3.4.3 Sample size  
 
Sample size was calculated with power and sample size calculation software  
PS Version 2.1.31  
α = 0.05 
power =0.8 
σ (Sandard deviation) = 0.56 (Jivrajka et al., 2008)    
δ ( Detectable difference) = 0.2 
Estimated sample size-64 
Estimated non responder- 10%  
Sample Size required - 64 + 6= 70 eyes 
 
 
3.5 SELECTION CRITERIA  
 
3.5.1 Inclusion criteria 
1) Patients on hemodialysis 
2) Hemodialysis duration: 1month – 5years 
3) Phakic eyes   
4) Age between 20 to 70 years old 
 
3.5.2 Exclusion criteria  
1) Pseudopakic and aphakic eyes  
2) Congenital ocular abnormalities  
3) Cornea abnomalities 
 19 
4) Ectopia lentis 
5) Any known retinal or  choroidal detachment 
6) Any known glaucoma , uveitis  or pseudoexfoliation 
7) History of previous ocular trauma or surgery 
8) High myopia  and  high hypermetropia  
 
 
3.6 DEFINITION OF TERMS 
 
3.6.1 Lens thickness 
 
Crystalline lens in human is a transparent, biconvex structure situated behind the iris and 
the pupil and in front of the vitreous body. The center points on its anterior and posterior 
surfaces are anterior and posterior poles of the lens respectively. The line joining the 
poles forms the axis of the lens ( Snell & Lemp, 1998). The lens thickness is the axis of 
the lens. It is also referred as the anteroposterior diameter of the lens. Lens thickness 
varies with age between 3.5mm at birth to 5mm in adult ( Khurana, 2002).   
 
3.6.2 Anterior chamber depth 
 
Anterior chamber is the space that bounded anteriorly by the endothelial layer of cornea 
and posteriorly by the anterior surface of iris and part of ciliary body. Anterior chamber 
depth is divided to central and peripheral anterior chamber depth. At the peripheral part 
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of the anterior chamber depth is the corner between the cornea, sclera, ciliary body, and 
iris that referred as angle of anterior chamber. The central anterior chamber depth is 3mm 
in normal adults ( Snell & Lemp, 1998). The anterior chamber depth has inverse 
association with age and spherical refractive errors (He et al., 2008 ).   It is relatively 
shallow in very young children and old people (Khurana, 2002).   
 
3.6.3 Intraocular pressure 
 
Intraocular pressure refers to the pressure exerted by intraocular contents on the coats of 
the eyeball. Dynamic equilibrium between the aqueous humour formation, outflow 
facility and episcleral venous pressure are essential to maintain the normal intraocular 
pressure. The distribution of intraocular pressure within general population has a range of 
11mmHg to 21mmHg. There is diurnal variation of intraocular pressure , with a tendency 
to be higher in the morning  and lower in the afternoon and evening (Kanski, 2003). 
 
3.6.4 Hemodialysis 
 
Hemodialysis is a vascular access method of renal replacement therapy in renal failure 
based on the mechanism of diffusion of solutes across concentration gradient via a 
semipermeable membrane.  It helps to remove waste products such creatinine and urea, 
as well as free water from the blood.  It also provide adequate correction of fluid-
electrolyte and acid-base abnormalities (Horl et al., 2004) 
 
 21 
3.6.5 End stage renal failure 
 
Kidney Diseases Outcomes Quality Initiative (K/DOQI) of the National Kidney 
Foundation (NKF) defines chronic kidney disease as either kidney damage or a decreased 
glomerular filtration rate (GFR) of less than 60mL/min/1.73m2 for 3 or more months. 
End stage renal failure is the progressive loss of kidney function. The glomerular 
filtration rate (GFR)  is less than 15 mL/min/1.73 m2 in end stage renal failure. Renal 
replacement therapy such as dialysis is needed at this stage (Eknoyan, 2002) 
 
 
3.7 INSTRUMENTS 
 
3.7.1  SCREENING INSTRUMENTS 
 
(a) Snellen Acuity Chart 
 
Snellen acuity chart (Rus IOL Enterprise, England) was used to assess the visual acuity 
of  patients. The visual acuity of each eye was checked at 6 metres under normal room 
lighting. 
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(b) Slit Lamp Biomicroscope, Condensing lens and Tonometer 
 
Nikon SL FS-3 (Nikon, Japan) slit lamp was used to examine the anterior and posterior 
segment of the eye. The posterior segment was examined with a 90D condensing lens 
(Volk, USA). The intraocular pressure was elicited with a goldmann applanation 
tonometer (Haag Streit, Switzerland).  
 
(c) Retinoscope, Trial Lenses  and Frame 
 
Retinoscope (Heine, Germany), trial lenses and frame (Merck Sharp & Dohme, Italy) 
were used to assess the refraction status of the patients. 
 
(d) Topical Eye Medication 
  
Topical tropicamide 1.0% (Alcon, Spain) was used to dilate pupils for proper fundus 
examination. Topical proparacaine hydrochloride 0.5% (Alcon, Belgium) and fluorescein 
sodium/ Fluorets strip (Chauvin, England) were used to elicit the intraocular pressure.  
 
(e) Goniolens  and Coupling Gel 
 
Goldmann 3-mirror lens (Ocular, USA) and hypromellose/ Genteal 0.3% (Norvartis, 
Switzerland) were used to assess the angle of the anterior chamber. The grading of angle 
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was based on Shaffer classification. Topical anaesthesia , proparacaine hydrochloride 
0.5% (Alcon, Belgium) was applied to the eye prior to gonioscopy. 
 
(f) Humphrey Visual Field Analyzer II 
 
Assessment of visual field of patients was done with Humphrey visual field analyzer II 
(Carl Zeiss, Germany). The visual field was assessed in SITA Fast 24-2 with stimulus 
size 3 (1mm). 
 
 
3.7.2 STUDY INSTRUMENTS 
 
(a) A-scan 
 
A-scan (Sonomed PAC SCAN 300 A, USA) was used to measure the lens thickness and 
anterior chamber depth of study subjects at 0hour, 2hour and 4hour of hemodialysis. A-
scan was set in automatic mode with sound or tissue velocity (TVEL) 1532m/s for 
anterior chamber depth, 1641m/s for lens, and 1532m/s for vitreous. Topical anaesthesia 
was applied to the eye prior to A-scan examination (Figure 3.1) 
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(b) Perkins Tonometer 
 
Perkins tonometer (Clement Clarke International, UK) is a portable, handheld 
applanation tonometer. It was used to measure the intraocular pressure of study subjects 
at 0hour, 2hour and 4hour of hemodialysis.  Fluorescein sodium/ Fluorets strip (Chauvin, 
England) together with topical anaesthesia were applied to the eye prior to Perkins 
tonometer examination (Figure 3.1) 
 
(c) Topical Anaesthesia 
 
Topical proparacaine hydrochloride 0.5% (Alcon, Belgium) is a rapidly-acting topical 
anaesthetic that induced local anaesthesia lasting 10 minutes to 20 minutes.  
 
Figure 3.1: Mobile unit -  A-scan and Perkins tonometer for lens thickness, anterior  
     chamber depth and intraocular pressure measurement. 
